Yang Zhongsheng, Zhai Qiliang, Wu Junjing, Song Leming, Huang Yongming, Sun Ting
Department of Urology, The Affiliated Ganzhou Hospital, Jiangxi Medical College, Nanchang University, Ganzhou, China.
Department of Urology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Urolithiasis. 2025 Jun 28;53(1):129. doi: 10.1007/s00240-025-01799-w.
We performed a comparative analysis of intelligent pressure-controlled ureteroscopic lithotripsy (IRIRS) and intelligent pressure-controlled microchannel percutaneous nephrolithotomy (IMPCNL) to treat 2-3 cm renal calculi. Patients (n = 140) with 2-3 cm renal calculi were randomly divided into the IRIRS and IMPCNL groups (n = 70/group). Surgical time, length of hospital stays, stone clearance rate, decrease in hemoglobin level, postoperative pain score, and incidence of complications were compared between groups. The IRIRS group had significantly longer operative durations than the IMPCNL group (average: 58.3 ± 7.4 vs. 52.5 ± 6.8 min). Stone clearance rates at 4 weeks postoperatively were 90.0% and 92.8% in the IRIRS and IMPCNL groups, respectively (P > 0.05). The IRIRS group had shorter hospital stays than the IMPCNL group (1.9 ± 0.3 vs. 3.2 ± 0.4 days). Intraoperative hemoglobin levels decreased more in the IMPCNL (1.03 ± 0.12 g/dL) than in the IRIRS (0.25 ± 0.06 g/dL, P < 0.001) group. Two and one cases in the IRIRS and IMPCNL group, respectively, experienced postoperative fever. The overall complication incidence did not significantly differ (12.9% IRIRS and 15.7% IMPCNL; P > 0.05). IRIRS and IMPCNL are safe, effective interventions for 2-3 cm renal calculi. Given its minimally invasive nature and positive operative safety outcomes, IRIRS has promising future applications.
我们对智能压力控制输尿管镜碎石术(IRIRS)和智能压力控制微通道经皮肾镜取石术(IMPCNL)治疗2-3厘米肾结石进行了对比分析。将140例患有2-3厘米肾结石的患者随机分为IRIRS组和IMPCNL组(每组70例)。比较两组之间的手术时间、住院时间、结石清除率、血红蛋白水平下降情况、术后疼痛评分及并发症发生率。IRIRS组的手术持续时间显著长于IMPCNL组(平均:58.3±7.4分钟 vs. 52.5±6.8分钟)。术后4周时,IRIRS组和IMPCNL组的结石清除率分别为90.0%和92.8%(P>0.05)。IRIRS组的住院时间短于IMPCNL组(1.9±0.3天 vs. 3.2±0.4天)。IMPCNL组术中血红蛋白水平下降幅度(1.03±0.12g/dL)大于IRIRS组(0.25±0.06g/dL,P<0.001)。IRIRS组和IMPCNL组分别有2例和1例患者术后发热。总体并发症发生率无显著差异(IRIRS组为12.9%,IMPCNL组为15.7%;P>0.05)。IRIRS和IMPCNL是治疗2-3厘米肾结石的安全、有效干预措施。鉴于其微创性质和良好的手术安全性结果,IRIRS具有广阔的应用前景。